INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Results

73,241 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
11
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$125K
480 sh
Page 159 of 1832
← PrevNext →
Oct 29, 2026
Nov 2, 2026
traded Oct 29, 2026
+4d
SEC Form 4

Evidence

11
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$52K
200 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

11
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$84K
320 sh
Oct 29, 2026Nov 2, 2026
traded Oct 29, 2026
+4dSEC Form 4

Evidence

11
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$96K
360 sh
Oct 29, 2026Nov 2, 2026
traded Oct 29, 2026
+4dSEC Form 4

Evidence

11
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$160K
640 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

11
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$244K
958 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

11
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$52K
200 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

11
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$62K
240 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

10
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
2,859 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

10
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
3,750 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

10
SM
Stumpf MatthewChief Financial Officer (CFO)
APPAppLovin Corp
Grant or award
A—
54.9K sh
Oct 29, 2026Nov 2, 2026
traded Oct 29, 2026
+4dSEC Form 4

Evidence

10
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
2,859 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

10
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
3,573 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

9
KC
Krosnowski Scott CarrollChief Financial Officer
QMLSQumulusAI, Inc.
Option exercise
M—
50.7K sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

9
JW
Jeggle Helmut WolfgangDirector, 10% Owner
BBTXBambusa Therapeutics, Inc.
Derivative conversion
C—
1.47M sh
Nov 2, 2026Nov 2, 2026
traded Nov 2, 2026
+0dSEC Form 4

Evidence

9
DJ
DiCiollo Anthony JHead of Institutional Segment
SNEXStoneX Group Inc.
Grant or award
A—
6,604 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

9
SG
Salvia Investment GmbH10% Owner
BBTXBambusa Therapeutics, Inc.
Derivative conversion
C—
1.47M sh
Nov 2, 2026Nov 2, 2026
traded Nov 2, 2026
+0dSEC Form 4

Evidence

9
XS
Xu ShanshanDirector, See remarks, 10% Owner
BBTXBambusa Therapeutics, Inc.
Derivative conversion
C—
4,155 sh
Nov 2, 2026Nov 2, 2026
traded Nov 2, 2026
+0dSEC Form 4

Evidence

9
RT
2018 Reed Dynasty Trust10% Owner
ARHSArhaus, Inc.
Derivative conversion
C—
192.9K sh
Oct 29, 2026Nov 2, 2026
traded Oct 29, 2026
+4dSEC Form 4

Evidence

9
PJ
Paulson JohnDirector
BLCOBausch & Lomb Corp
Grant or award
A$23K
1,125 sh
Oct 29, 2026Nov 2, 2026
traded Oct 29, 2026
+4dSEC Form 4

Evidence

9
BD
Brown Kevin D.Director
HAYWHayward Holdings, Inc.
Grant or award
A—
1,446 sh
Oct 29, 2026Nov 2, 2026
traded Oct 29, 2026
+4dSEC Form 4

Evidence

9
BJ
Boattini JenniferSR VP Legal/General Counsel
JBHTHUNT J B TRANSPORT SERVICES INC
Tax withholding
F$40K
180 sh
Oct 31, 2026Nov 2, 2026
traded Oct 31, 2026
+2dSEC Form 4

Evidence

9
BJ
Boattini JenniferSR VP Legal/General Counsel
JBHTHUNT J B TRANSPORT SERVICES INC
Option exercise
M—
474 sh
Oct 31, 2026Nov 2, 2026
traded Oct 31, 2026
+2dSEC Form 4

Evidence

9
BJ
Boattini JenniferSR VP Legal/General Counsel
JBHTHUNT J B TRANSPORT SERVICES INC
Tax withholding
F$43K
196 sh
Oct 31, 2026Nov 2, 2026
traded Oct 31, 2026
+2dSEC Form 4

Evidence

9
BJ
Boattini JenniferSR VP Legal/General Counsel
JBHTHUNT J B TRANSPORT SERVICES INC
Option exercise
M—
528 sh
Oct 31, 2026Nov 2, 2026
traded Oct 31, 2026
+2dSEC Form 4

Evidence

9
AS
Awsare SaleelDirector, President & CEO
LTRXLANTRONIX INC
Option exercise
M—
156.8K sh
Nov 1, 2026Nov 2, 2026
traded Nov 1, 2026
+1dSEC Form 4

Evidence

9
VH
van Houte HansChief Financial Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
2,859 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

9
WG
Woodruff Ronald GreerEVP Safety, ESG, Maintenance
JBHTHUNT J B TRANSPORT SERVICES INC
Option exercise
M—
230 sh
Oct 31, 2026Nov 2, 2026
traded Oct 31, 2026
+2dSEC Form 4

Evidence

9
EL
Evans Terry LChief Commercial Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A—
168 sh
Oct 31, 2026Nov 2, 2026
traded Oct 31, 2026
+2dSEC Form 4

Evidence

9
CM
Cioffi Christiana MarieChief Strategy Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A—
156 sh
Oct 31, 2026Nov 2, 2026
traded Oct 31, 2026
+2dSEC Form 4

Evidence

9
SG
Salvia Investment GmbH10% Owner
BBTXBambusa Therapeutics, Inc.
Derivative conversion
C—
3.14M sh
Nov 2, 2026Nov 2, 2026
traded Nov 2, 2026
+0dSEC Form 4

Evidence

9
MM
Mulhall Christopher M.VP - Chief Accounting Officer
FTVFortive Corp
Option exercise
M—
3,532 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

9
RT
2018 Reed Dynasty Trust10% Owner
ARHSArhaus, Inc.
Derivative conversion
C—
192.9K sh
Oct 29, 2026Nov 2, 2026
traded Oct 29, 2026
+4dSEC Form 4

Evidence

9
GJ
Gahan Patrick JosephDirector
QMLSQumulusAI, Inc.
Option exercise
M—
24.4K sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

9
KC
Krosnowski Scott CarrollChief Financial Officer
QMLSQumulusAI, Inc.
Option exercise
M$14K
4,740 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

9
VH
van Houte HansChief Financial Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
3,750 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

9
CL
Cooper Diane L.Director
SNEXStoneX Group Inc.
Grant or award
A—
164 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

9
MM
Mulhall Christopher M.VP - Chief Accounting Officer
FTVFortive Corp
Option exercise
M—
3,351 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC Form 4

Evidence

9
SG
Salvia Investment GmbH10% Owner
BBTXBambusa Therapeutics, Inc.
Derivative conversion
C—
160.9K sh
Nov 2, 2026Nov 2, 2026
traded Nov 2, 2026
+0dSEC Form 4

Evidence

9
SP
Schwartz Barry PaulDirector
QMLSQumulusAI, Inc.
Option exercise
M$331
479 sh
Nov 2, 2026Nov 2, 2026
traded Nov 2, 2026
+0dSEC Form 4

Evidence